Neonatal Encephalopathy clinical trials
8 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- Neonatal Neurological Observation With Video AI
- Genetics of Neonatal Encephalopathy and Related Disorders
- Healthy Little Eyes
- Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
- Families Filming Infants Learning Movement
- Natural History Study of Patients with HPDL Mutations
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neonatal Encephalopathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.